Literature DB >> 29161806

Young Academic Urologists' benign prostatic obstruction nomogram predicts clinical outcome in patients treated with transurethral resection of prostate: an Italian cohort study.

Cosimo DE Nunzio1, Riccardo Lombardo2, Antonio Nacchia2, Marianna Deroma2, Hassan Alkhatatbeh3, Aldo Brassetti2, Andrea Tubaro2.   

Abstract

BACKGROUND: The aim of this study was to test the Young Academic Urologist nomogram for the prediction of transurethral resection of prostate outcome in patients with lower urinary tract symptoms and benign prostatic enlargement.
METHODS: Between April 2014 and March 2016, a consecutive series of patients with lower urinary tract symptoms undergoing trans-urethral resection of prostate in one center were enrolled. At baseline patients were assessed with international prostate symptom score, prostate specific antigen, prostate volume, transitional zone volume, maximal urinary flow rate and post void residual urine. At 3 months after trans-urethral resection of prostate patients were evaluated with uroflowmetry and international prostate symptom score questionnaire. Maximum urinary flow and transitional zone volume were plotted on the Young Academic Urologist nomogram to predict trans-urethral resection of prostate outcome. Receiver-operator characteristics curve analysis was used to evaluate predictive properties of the nomogram for the outcome of transurethral resection of the prostate.
RESULTS: A total of 232 patients were consecutively enrolled. Out of them, 149 patients (65%) presented a positive outcome. The novel Young Academic Urologist nomogram presented an area under the curve of 0.77 (95% CI: 0.70-0.83) for trans-urethral resection of prostate outcome prediction. At the best cut-off value of 75% (nomogram probability) the sensitivity was 62% and specificity was 73%, the positive predictive value was 81% and the negative predictive value was 52%.
CONCLUSIONS: The Young Academic Urologist nomogram was, in our experience, an excellent tool to predict a positive outcome after transurethral resection of prostate, although further studies are needed to confirm our results.

Entities:  

Mesh:

Year:  2017        PMID: 29161806     DOI: 10.23736/S0393-2249.17.03008-9

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  5 in total

Review 1.  Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review.

Authors:  Riccardo Bertolo; Cristian Fiori; Daniele Amparore; Francesco Porpiglia
Journal:  Curr Urol Rep       Date:  2018-04-26       Impact factor: 3.092

2.  The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.

Authors:  Ye Tian; Heng Zhang; Ying Cao; Lu Yang; Guangheng Luo
Journal:  Clin Interv Aging       Date:  2022-05-23       Impact factor: 3.829

3.  Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.

Authors:  Cosimo De Nunzio; Francesco Cantiello; Cristian Fiori; Fabio Crocerossa; Piero Tognoni; Daniele Amparore; Valeria Baldassarri; Javier Reinoso Elbers; Fernando Gomez Sancha; Francesco Porpiglia
Journal:  World J Urol       Date:  2020-08-26       Impact factor: 4.226

4.  The role of intra-operative void score during transurethral resection of prostate as a marker of efficacy: a feasibility study.

Authors:  Christian Robinson; Alastair Hepburn; Robin M Turner; Amir D Zarrabi
Journal:  ANZ J Surg       Date:  2022-03-30       Impact factor: 2.025

5.  Development of a nomogram predicting the probability of stone free rate in patients with ureteral stones eligible for semi-rigid primary laser uretero-litothripsy.

Authors:  Cosimo De Nunzio; Jamil Ghahhari; Riccardo Lombardo; Giorgio Ivan Russo; Ana Albano; Antonio Franco; Valeria Baldassarri; Antonio Nacchia; Juan Lopez; Pilar Luque; Maria Jose Ribal; Antonio Alcaraz; Andrea Tubaro
Journal:  World J Urol       Date:  2021-06-26       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.